Evan David Seigerman Score: 37
Analyst at
BMO Capital
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+4.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
56%
27 W / 21 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
68%
25 W / 12 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
22%
8 W / 29 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
3%
1 W / 36 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
63%
12 W / 7 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
59%
26 W / 18 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
25%
1 W / 3 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$184.00
Est. +11%
|
$165.61 | $175.65 |
Pending
|
$174.48
+5.4%
|
| Oct 19, 2026 |
Disc Medicine Inc
IRON
|
BUY |
$120.00
Est. +57%
|
$76.56 | $85.00 |
Pending
|
$83.28
+8.8%
|
| Oct 01, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$920.00
Est. +24%
|
$741.41 | $991.73 |
Target Met
|
$930.67
+25.5%
|
| Sep 08, 2026 |
BioNTech SE - ADR
BNTX
|
BUY |
$105.00
Est. +1%
|
$103.76 | $103.00 |
Precision Hit (±3%)
|
$90.70
-12.6%
|
| Jul 01, 2026 |
AMGEN Inc.
AMGN
|
BUY |
$400.00
Est. +10%
|
$362.45 | $482.48 |
Target Met
|
$478.48
+32.0%
|
| Jun 22, 2026 |
Incyte Corp.
INCY
|
SELL |
$94.00
Est. +4%
|
$98.22 | $99.79 (Low) |
Pending
|
$122.89
-25.1%
|
| Mar 11, 2026 |
BioNTech SE - ADR
BNTX
|
BUY |
$128.00
Est. +41%
|
$90.52 | $116.87 |
Pending
|
$90.70
+0.2%
|
| Mar 09, 2026 |
Pfizer Inc.
PFE
|
BUY |
$30.00
Est. +13%
|
$26.49 | $31.05 |
Target Met
|
$30.79
+16.2%
|
| Mar 02, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$600.00
Est. +23%
|
$487.57 | $568.67 |
Pending
|
$549.04
+12.6%
|
| Jan 26, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$150.00
Est. +9%
|
$137.01 | $175.65 |
Target Met
|
$174.48
+27.3%
|
| Jan 15, 2026 |
Abbvie Inc
ABBV
|
BUY |
$258.00
Est. +18%
|
$217.74 | $298.73 |
Target Met
|
$294.90
+35.4%
|
| Nov 25, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$135.00
Est. +6%
|
$127.57 | $175.65 |
Target Met
|
$174.48
+36.8%
|
| Oct 31, 2025 |
Merus N.V
MRUS
|
BUY |
$97.00
Est. +2%
|
$94.90 | $97.02 |
Bullseye Hit (±1%)
|
$90.00
-5.2%
|
| Nov 12, 2024 |
Abbvie Inc
ABBV
|
BUY |
$208.00
Est. +3%
|
$201.61 | $244.81 |
Target Met
|
$294.90
+46.3%
|
| Nov 05, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$112.00
Est. +77%
|
$63.24 | $95.95 |
Miss
|
$83.28
+31.7%
|
| Nov 01, 2024 |
Merck & Co Inc
MRK
|
BUY |
$136.00
Est. +33%
|
$101.88 | $105.07 |
Miss
|
$150.39
+47.6%
|
| Nov 01, 2024 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$57.00
Est. +5%
|
$54.32 | $63.33 |
Target Met
|
$64.20
+18.2%
|
| Nov 01, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,190.00
Est. +41%
|
$843.60 | $862.00 |
Miss
|
$930.67
+10.3%
|
| Oct 31, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$121.00
Est. +1%
|
$120.27 | $154.61 |
Target Met
|
$166.05
+38.1%
|
| Oct 31, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,010.00
Est. +22%
|
$829.74 | $935.63 |
Miss
|
$1,417.83
+70.9%
|
| Oct 31, 2024 |
Abbvie Inc
ABBV
|
BUY |
$228.00
Est. +13%
|
$201.50 | $244.81 |
Target Met
|
$294.90
+46.4%
|
| Oct 21, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$94.00
Est. +9%
|
$86.11 | $124.61 |
Target Met
|
$174.48
+102.6%
|
| Oct 21, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$566.00
Est. +17%
|
$485.74 | $519.88 |
Miss
|
$549.04
+13.0%
|
| Sep 25, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$362.00
Est. +9%
|
$330.92 | $335.88 |
Miss
|
$478.48
+44.6%
|
| Sep 23, 2024 |
Bristol-Myers Squibb Co.
BMY
|
SELL |
$48.00
Est. +3%
|
$49.56 | $42.99 (Low) |
Target Met
|
$64.20
-29.5%
|
| Sep 13, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$128.00
Est. +5%
|
$122.29 | $154.61 |
Target Met
|
$166.05
+35.8%
|
| Sep 12, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,300.00
Est. +12%
|
$1,159.95 | $1,170.58 |
Miss
|
$930.67
-19.8%
|
| Aug 09, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,101.00
Est. +30%
|
$845.31 | $972.53 |
Miss
|
$1,417.83
+67.7%
|
| Aug 09, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$85.00
Est. +12%
|
$75.59 | $121.38 |
Target Met
|
$174.48
+130.8%
|
| Aug 08, 2024 |
Novo Nordisk - ADR
NVO
|
BUY |
$160.00
Est. +27%
|
$126.17 | $139.74 |
Miss
|
$42.17
-66.6%
|
| Jun 17, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$70.00
Est. +53%
|
$45.80 | $68.73 |
Precision Hit (±3%)
|
$83.28
+81.8%
|
| Jun 03, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,082.00
Est. +9%
|
$992.47 | $1,211.20 |
Target Met
|
$930.67
-6.2%
|
| May 31, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$500.00
Est. +13%
|
$443.05 | $519.88 |
Target Met
|
$549.04
+23.9%
|
| May 30, 2024 |
Merck & Co Inc
MRK
|
BUY |
$148.00
Est. +16%
|
$127.71 | $129.93 |
Miss
|
$150.39
+17.8%
|
| May 23, 2024 |
Biogen Inc
BIIB
|
BUY |
$260.00
Est. +18%
|
$220.00 | $237.98 |
Miss
|
$254.46
+15.7%
|
| May 20, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$80.00
Est. +18%
|
$67.90 | $119.69 |
Target Met
|
$174.48
+157.0%
|
| May 03, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$355.00
Est. +28%
|
$278.39 | $346.85 |
Precision Hit (±3%)
|
$478.48
+71.9%
|
| Apr 30, 2024 |
Incyte Corp.
INCY
|
SELL |
$52.00
Est. +0%
|
$52.05 | $53.56 (Low) |
Precision Hit (±3%)
|
$122.89
-136.1%
|
| Apr 18, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$900.00
Est. +20%
|
$748.40 | $972.53 |
Target Met
|
$1,417.83
+89.4%
|
| Apr 12, 2024 |
Novo Nordisk - ADR
NVO
|
BUY |
$163.00
Est. +30%
|
$125.40 | $143.69 |
Miss
|
$42.17
-66.4%
|
| Apr 02, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$50.00
Est. +46%
|
$34.21 | $68.73 |
Target Met
|
$83.28
+143.4%
|
| Sep 28, 2022 |
Biogen Inc
BIIB
|
BUY |
$360.00
Est. +82%
|
$197.79 | - | - |
$254.46
+28.7%
|
| May 08, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$358.00
Est. +21%
|
$296.90 | - | - |
$1,417.83
+377.5%
|
| Apr 10, 2022 |
Merck & Co Inc
MRK
|
SELL |
$87.00
Est. +1%
|
$87.68 | - | - |
$150.39
-71.5%
|
| Mar 17, 2022 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$74.00
Est. +5%
|
$70.52 | - | - |
$64.20
-9.0%
|
| Feb 21, 2022 |
AMGEN Inc.
AMGN
|
BUY |
$240.00
Est. +9%
|
$220.77 | - | - |
$478.48
+116.7%
|
| Feb 13, 2022 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$780.00
Est. +22%
|
$638.41 | - | - |
$930.67
+45.8%
|
Gilead Sciences, Inc.
GILD
Oct 30, 2026
Signal & Target
BUY
$184.00
Start Price
$165.61
Best Price (1Y)
$175.65
Current Price
$174.48
Return
+5.4%
Disc Medicine Inc
IRON
Oct 19, 2026
Signal & Target
BUY
$120.00
Start Price
$76.56
Best Price (1Y)
$85.00
Current Price
$83.28
Return
+8.8%
Regeneron Pharmaceuticals, Inc.
REGN
Oct 01, 2026
Signal & Target
BUY
$920.00
Start Price
$741.41
Best Price (1Y)
$991.73
Current Price
$930.67
Return
+25.5%
BioNTech SE - ADR
BNTX
Sep 08, 2026
Signal & Target
BUY
$105.00
Start Price
$103.76
Best Price (1Y)
$103.00
Current Price
$90.70
Return
-12.6%
AMGEN Inc.
AMGN
Jul 01, 2026
Signal & Target
BUY
$400.00
Start Price
$362.45
Best Price (1Y)
$482.48
Current Price
$478.48
Return
+32.0%
Incyte Corp.
INCY
Jun 22, 2026
Signal & Target
SELL
$94.00
Start Price
$98.22
Best Price (1Y)
$99.79
Current Price
$122.89
Return
-25.1%
BioNTech SE - ADR
BNTX
Mar 11, 2026
Signal & Target
BUY
$128.00
Start Price
$90.52
Best Price (1Y)
$116.87
Current Price
$90.70
Return
+0.2%
Pfizer Inc.
PFE
Mar 09, 2026
Signal & Target
BUY
$30.00
Start Price
$26.49
Best Price (1Y)
$31.05
Current Price
$30.79
Return
+16.2%
Vertex Pharmaceuticals, Inc.
VRTX
Mar 02, 2026
Signal & Target
BUY
$600.00
Start Price
$487.57
Best Price (1Y)
$568.67
Current Price
$549.04
Return
+12.6%
Gilead Sciences, Inc.
GILD
Jan 26, 2026
Signal & Target
BUY
$150.00
Start Price
$137.01
Best Price (1Y)
$175.65
Current Price
$174.48
Return
+27.3%
Abbvie Inc
ABBV
Jan 15, 2026
Signal & Target
BUY
$258.00
Start Price
$217.74
Best Price (1Y)
$298.73
Current Price
$294.90
Return
+35.4%
Gilead Sciences, Inc.
GILD
Nov 25, 2025
Signal & Target
BUY
$135.00
Start Price
$127.57
Best Price (1Y)
$175.65
Current Price
$174.48
Return
+36.8%
Merus N.V
MRUS
Oct 31, 2025
Signal & Target
BUY
$97.00
Start Price
$94.90
Best Price (1Y)
$97.02
Current Price
$90.00
Return
-5.2%
Abbvie Inc
ABBV
Nov 12, 2024
Signal & Target
BUY
$208.00
Start Price
$201.61
Best Price (1Y)
$244.81
Current Price
$294.90
Return
+46.3%
Disc Medicine Inc
IRON
Nov 05, 2024
Signal & Target
BUY
$112.00
Start Price
$63.24
Best Price (1Y)
$95.95
Current Price
$83.28
Return
+31.7%
Merck & Co Inc
MRK
Nov 01, 2024
Signal & Target
BUY
$136.00
Start Price
$101.88
Best Price (1Y)
$105.07
Current Price
$150.39
Return
+47.6%
Bristol-Myers Squibb Co.
BMY
Nov 01, 2024
Signal & Target
BUY
$57.00
Start Price
$54.32
Best Price (1Y)
$63.33
Current Price
$64.20
Return
+18.2%
Regeneron Pharmaceuticals, Inc.
REGN
Nov 01, 2024
Signal & Target
BUY
$1,190.00
Start Price
$843.60
Best Price (1Y)
$862.00
Current Price
$930.67
Return
+10.3%
Neurocrine Biosciences, Inc.
NBIX
Oct 31, 2024
Signal & Target
BUY
$121.00
Start Price
$120.27
Best Price (1Y)
$154.61
Current Price
$166.05
Return
+38.1%
Lilly(Eli) & Co
LLY
Oct 31, 2024
Signal & Target
BUY
$1,010.00
Start Price
$829.74
Best Price (1Y)
$935.63
Current Price
$1,417.83
Return
+70.9%
Abbvie Inc
ABBV
Oct 31, 2024
Signal & Target
BUY
$228.00
Start Price
$201.50
Best Price (1Y)
$244.81
Current Price
$294.90
Return
+46.4%
Gilead Sciences, Inc.
GILD
Oct 21, 2024
Signal & Target
BUY
$94.00
Start Price
$86.11
Best Price (1Y)
$124.61
Current Price
$174.48
Return
+102.6%
Vertex Pharmaceuticals, Inc.
VRTX
Oct 21, 2024
Signal & Target
BUY
$566.00
Start Price
$485.74
Best Price (1Y)
$519.88
Current Price
$549.04
Return
+13.0%
AMGEN Inc.
AMGN
Sep 25, 2024
Signal & Target
BUY
$362.00
Start Price
$330.92
Best Price (1Y)
$335.88
Current Price
$478.48
Return
+44.6%
Bristol-Myers Squibb Co.
BMY
Sep 23, 2024
Signal & Target
SELL
$48.00
Start Price
$49.56
Best Price (1Y)
$42.99
Current Price
$64.20
Return
-29.5%
Neurocrine Biosciences, Inc.
NBIX
Sep 13, 2024
Signal & Target
BUY
$128.00
Start Price
$122.29
Best Price (1Y)
$154.61
Current Price
$166.05
Return
+35.8%
Regeneron Pharmaceuticals, Inc.
REGN
Sep 12, 2024
Signal & Target
BUY
$1,300.00
Start Price
$1,159.95
Best Price (1Y)
$1,170.58
Current Price
$930.67
Return
-19.8%
Lilly(Eli) & Co
LLY
Aug 09, 2024
Signal & Target
BUY
$1,101.00
Start Price
$845.31
Best Price (1Y)
$972.53
Current Price
$1,417.83
Return
+67.7%
Gilead Sciences, Inc.
GILD
Aug 09, 2024
Signal & Target
BUY
$85.00
Start Price
$75.59
Best Price (1Y)
$121.38
Current Price
$174.48
Return
+130.8%
Novo Nordisk - ADR
NVO
Aug 08, 2024
Signal & Target
BUY
$160.00
Start Price
$126.17
Best Price (1Y)
$139.74
Current Price
$42.17
Return
-66.6%
Disc Medicine Inc
IRON
Jun 17, 2024
Signal & Target
BUY
$70.00
Start Price
$45.80
Best Price (1Y)
$68.73
Current Price
$83.28
Return
+81.8%
Regeneron Pharmaceuticals, Inc.
REGN
Jun 03, 2024
Signal & Target
BUY
$1,082.00
Start Price
$992.47
Best Price (1Y)
$1,211.20
Current Price
$930.67
Return
-6.2%
Vertex Pharmaceuticals, Inc.
VRTX
May 31, 2024
Signal & Target
BUY
$500.00
Start Price
$443.05
Best Price (1Y)
$519.88
Current Price
$549.04
Return
+23.9%
Merck & Co Inc
MRK
May 30, 2024
Signal & Target
BUY
$148.00
Start Price
$127.71
Best Price (1Y)
$129.93
Current Price
$150.39
Return
+17.8%
Biogen Inc
BIIB
May 23, 2024
Signal & Target
BUY
$260.00
Start Price
$220.00
Best Price (1Y)
$237.98
Current Price
$254.46
Return
+15.7%
Gilead Sciences, Inc.
GILD
May 20, 2024
Signal & Target
BUY
$80.00
Start Price
$67.90
Best Price (1Y)
$119.69
Current Price
$174.48
Return
+157.0%
AMGEN Inc.
AMGN
May 03, 2024
Signal & Target
BUY
$355.00
Start Price
$278.39
Best Price (1Y)
$346.85
Current Price
$478.48
Return
+71.9%
Incyte Corp.
INCY
Apr 30, 2024
Signal & Target
SELL
$52.00
Start Price
$52.05
Best Price (1Y)
$53.56
Current Price
$122.89
Return
-136.1%
Lilly(Eli) & Co
LLY
Apr 18, 2024
Signal & Target
BUY
$900.00
Start Price
$748.40
Best Price (1Y)
$972.53
Current Price
$1,417.83
Return
+89.4%
Novo Nordisk - ADR
NVO
Apr 12, 2024
Signal & Target
BUY
$163.00
Start Price
$125.40
Best Price (1Y)
$143.69
Current Price
$42.17
Return
-66.4%
Disc Medicine Inc
IRON
Apr 02, 2024
Signal & Target
BUY
$50.00
Start Price
$34.21
Best Price (1Y)
$68.73
Current Price
$83.28
Return
+143.4%
Biogen Inc
BIIB
Sep 28, 2022
Signal & Target
BUY
$360.00
Start Price
$197.79
Best Price (1Y)
-
Current Price
$254.46
Return
+28.7%
Lilly(Eli) & Co
LLY
May 08, 2022
Signal & Target
BUY
$358.00
Start Price
$296.90
Best Price (1Y)
-
Current Price
$1,417.83
Return
+377.5%
Merck & Co Inc
MRK
Apr 10, 2022
Signal & Target
SELL
$87.00
Start Price
$87.68
Best Price (1Y)
-
Current Price
$150.39
Return
-71.5%
Bristol-Myers Squibb Co.
BMY
Mar 17, 2022
Signal & Target
BUY
$74.00
Start Price
$70.52
Best Price (1Y)
-
Current Price
$64.20
Return
-9.0%
AMGEN Inc.
AMGN
Feb 21, 2022
Signal & Target
BUY
$240.00
Start Price
$220.77
Best Price (1Y)
-
Current Price
$478.48
Return
+116.7%
Regeneron Pharmaceuticals, Inc.
REGN
Feb 13, 2022
Signal & Target
BUY
$780.00
Start Price
$638.41
Best Price (1Y)
-
Current Price
$930.67
Return
+45.8%